(SEM) Select Medical Holdings - Ratings and Ratios

Select Medical Holdings Corporation is a leading operator of specialized healthcare facilities in the United States, providing critical care and rehabilitation services through its extensive network of hospitals and outpatient clinics. The companys diversified service portfolio caters to a wide range of medical needs, from critical illness recovery and rehabilitation to outpatient therapy programs, positioning it as a significant player in the healthcare sector.

The companys operational segments are strategically focused on high-demand areas: Critical Illness Recovery Hospitals provide intensive care for complex conditions; Rehabilitation Hospitals offer comprehensive therapy and rehabilitation services for patients with severe injuries or conditions; and Outpatient Rehabilitation clinics deliver a broad spectrum of rehabilitation programs. This diversified model allows Select Medical Holdings to capitalize on various revenue streams within the healthcare industry.

With a history dating back to 1996, Select Medical Holdings has established itself as a prominent healthcare provider, headquartered in Mechanicsburg, Pennsylvania. For more detailed information, the companys official website (https://www.selectmedical.com) offers insights into its services, operations, and corporate governance.

Analyzing the and , we observe that Select Medical Holdings (SEM) is currently trading at $15.20, slightly above its SMA20 but below its SMA50 and significantly below its SMA200, indicating a potential downtrend in the medium to long term. The ATR suggests a daily volatility of 3.71%, which is moderate. The stock is also far from its 52-week high of $21.43 and closer to its 52-week low of $14.20, indicating a bearish sentiment in the market.

From a fundamental perspective, with a market capitalization of $1944.80M USD and a P/E ratio of 24.80, SEM is considered a mid-cap stock with a relatively high valuation compared to its earnings. However, the forward P/E of 14.18 suggests expected earnings growth, potentially driven by the increasing demand for healthcare services. The Return on Equity (RoE) of 10.33% is respectable, indicating the companys ability to generate profits from shareholders equity.

Forecasting the future performance of SEM based on the provided data, a potential trend reversal or stabilization could be anticipated if the stock manages to break through its SMA50 resistance at $15.67. A sustained move above this level, accompanied by positive fundamental news or an increase in healthcare demand, could drive the stock towards its SMA200 at $17.93. Conversely, failure to break through this resistance, coupled with the current bearish sentiment indicated by its proximity to the 52-week low, might lead to further decline. Investors should closely monitor the stocks price action relative to its moving averages and be aware of any shifts in the healthcare landscape that could impact SEMs operational segments.